Expansion of a CAG repeat in the Huntington's disease (HD) gene results in progressive neuronal loss, particularly of striatal mediumsized spiny neurons (MSNs). Studies in human HD autopsy brain tissue, as well as cellular and animal models of HD, suggest that increased activity of NMDA-type glutamate receptors and altered mitochondrial function contribute to selective neuronal degeneration. In this regard, the YAC128 mouse model, expressing full-length human huntingtin with 128 glutamine repeats, has been the focus of much interest. Although NMDA-induced apoptosis is enhanced in YAC128 MSNs, here we report that the initial steps in the death signaling pathway, including NMDA receptor (NMDAR) current and cytosolic Ca 2ϩ loading, are similar to those observed in wild-type MSNs. In contrast, we found that the NMDAR-mediated Ca 2ϩ load triggered a strikingly enhanced loss of mitochondrial membrane potential in YAC128 MSNs, suggesting that NMDAR signaling via the mitochondrial apoptotic pathway is altered. This effect was accompanied by impaired cytosolic Ca 2ϩ clearance after removal of NMDA, a difference that was not apparent after high potassium-evoked depolarization-mediated Ca 2ϩ entry. Inhibition of the mitochondrial permeability transition (mPT) reduced peak cytosolic Ca 2ϩ and mitochondrial depolarization evoked by NMDA in YAC128 MSNs but not wild-type MSNs. Hence, in contrast to YAC models with moderate CAG expansions, the enhanced NMDA-induced apoptosis in YAC128 MSNs is predominantly determined by augmented mitochondrial sensitivity to Ca 2ϩ -induced activation of the mPT. These results suggest that the CAG repeat length influences the mechanism by which mHtt enhances NMDAR-mediated excitotoxicity.
Introduction
Progressive neurodegeneration in Huntington's disease (HD) is caused by a CAG repeat expansion in exon 1 of the HD gene. The resulting polyglutamine (polyQ) expansion in the 350 kDa cytosolic protein huntingtin (Htt) is associated with typical adult onset disease for repeat lengths of 40 -55, whereas more extreme expansions cause juvenile onset and a distinct clinical presentation (Bittenbender and Quadfasel, 1962; van Dijk et al., 1986; Brinkman et al., 1997) . Neuronal loss is most severe among the medium-sized spiny neurons (MSNs) of the neostriatum (Vonsattel et al., 1985) , whereas Htt expression is widespread (Strong et al., 1993) . Transcriptional interference (Cha, 2000; LuthiCarter et al., 2000; Zuccato et al., 2001) , protein aggregation, and inhibition of the proteasomal machinery (Ross, 2002) mediated by polyQ-expanded (mutant) Htt (mHtt) may contribute to neuronal dysfunction and/or death. Caspase and calpain activation also occur in HD (Kim et al., 2001; Wellington et al., 2002) , and mHtt cleavage by caspase-6 is critical for producing clinical features and neurodegeneration typical of HD in a transgenic mouse model (Graham et al., 2006b ). However, it remains unclear how proteolytic cleavage, mHtt nuclear translocation, and transcriptional dysregulation are selectively activated in HD striatal neurons.
Previous studies in autopsy brain tissue from humans with HD have suggested that excitotoxicity resulting from overactivation of NMDA-type glutamate receptors (NMDARs) in combination with impaired mitochondrial function contributes to the relatively selective dysfunction and death of striatal neurons . Additionally, increased NMDARmediated current has been recorded in striatal MSNs from several transgenic HD mouse models Laforet et al., 2001 ; Zeron et al., 2002 Zeron et al., , 2004 . The yeast artificial chromosome (YAC) transgenic mouse model of HD expresses the full-length human HD gene with 18, 46, 72, or 128 CAG repeats (Hodgson et al., 1999; Slow et al., 2003) . YAC mice expressing expanded Htt exhibit motor and cognitive impairment, as well as striatal degeneration, typical of HD (Hodgson et al., 1999; Slow et al., 2003; Van Raamsdonk et al., 2005) ; these mice also show increased sensitivity to NMDA-induced apoptosis in MSNs cultured from early postnatal pups (Zeron et al., 2002; Graham et al., 2006b; Shehadeh et al., 2006) . YAC128 mice, carrying a more extreme CAG expansion than the other YAC HD mouse models, show an accelerated phenotype and significant striatal neurodegeneration by 6 -12 months (Slow et al., 2003) . Here, we examined the sequence of events leading to the previously reported (Graham et al., 2006b ) enhanced NMDA-induced neuronal death in YAC128 compared with wild-type (WT) mouse MSNs and found some surprising differences compared with YAC46 and YAC72 MSNs (Zeron et al., 2002 (Zeron et al., , 2004 . Although NMDA-evoked currents and cytosolic calcium loads are similar for YAC128 and WT MSNs, YAC128 MSNs exhibit slowed cytosolic calcium clearance and enhanced sensitivity to induction of the mitochondrial permeability transition (mPT) in response to NMDA. Our results suggest that therapy targeted toward signaling downstream of NMDAR activation would be most effective in this more aggressive model of HD.
Materials and Methods
Preparation of primary striatal neurons. Primary neostriatal neuronal cultures were prepared from WT or YAC128 line 55 mouse pups, as described previously (Zeron et al., 2004; Shehadeh et al., 2006) . Briefly, sterile poly-D-lysine-coated coverslips were placed in 24-well plates and allowed to dry before culturing. Striata were dissected from postnatal day 0 (P0) to P1 mice in HBSS on ice and then digested in warmed (37°C) papain solution for 10 min. Cells were further dissociated using a series of reducing bore-size Pasteur pipettes in warmed trypsin inhibitor solution and transferred to warmed serum-free plating media [Neurobasal medium including 2% B27 without supplements (Invitrogen, Burlington, Ontario), 2 mM L-glutamine, and 1% penicillin/streptomycin]. Neurons were plated at a density of ϳ2.0 ϫ 10 5 cells per well and incubated (37°C, 5% CO 2 ) for 9 -12 d. Approximately 80 -90% of cells cultured in this serum-free medium have the characteristics of MSNs, as evidenced by morphology, DARPP-32 staining, and/or staining for the GABAergic neuronal marker GAD-65 (Hansson et al., 1999; Kovacs et al., 2001; Shehadeh et al., 2006) . In all experiments, measurements were taken only from cells with morphological features consistent with MSNs, including an ovoid soma with a short diameter of ϳ10 m and two to four closely projecting processes (Shi and Rayport, 1994) .
Electrophysiological experiments. All cells were used for electrophysiological analysis at 9 -11 d in vitro (DIV). Coverslipped cultured MSNs were placed in the recording chamber on the stage of an inverted microscope (Axiovert 100; Carl Zeiss, Thornburg, NY). Intracellular recording solution contained the following: 115 mM CsMeSO 3 , 10 mM HEPES, 10 mM BAPTA, 4 mM Mg-ATP, 20 mM K 2 -creatine phosphate, and 50 U/ml creatine phosphokinase, titrated to pH 7.25 using CsOH and with an osmolarity of 309 -310 mOsm. Extracellular recording solution contained the following: 167 mM NaCl, 2.4 mM KCl, 1.8 mM CaCl 2 , 10 mM HEPES, and 10 mM D-(ϩ) glucose, titrated to pH 7.3 using NaOH and with an osmolarity of 325 mOsm. Both intracellular and extracellular solutions were filtered before use. In all experiments, 50 M glycine and 0.3 M TTX (to block voltage-gated sodium currents) were added to all extracellular solutions. Perfusion of neurons with different agonist solutions was achieved using a gravity-fed solenoid system attached to a theta tube. Currents were sampled at 5 kHz and acquired and analyzed using pCLAMP software and an Axopatch 200A amplifier (Molecular Devices, Foster City, CA). Current amplitude measurement and kinetics fittings were performed using Clampfit software.
Measurement of current density, steady-state to peak ratio, and ifenprodil sensitivity. Primary cultures of MSNs were prepared as described, and whole-cell currents were recorded under voltage clamp (V H ϭ Ϫ60 mV) in nominally Mg 2ϩ -free conditions. All currents were leak-subtracted before analysis. NMDAR currents were elicited by a 4 s application of 1 mM NMDA. This was repeated twice at 60 s intervals, for a total of three separate trials. Peak current density was calculated by dividing the peak current amplitude by the cell capacitance, thus normalizing current to cell surface area (allowing comparisons between cells with potentially different membrane surface areas). NMDAR steady-state to peak current ratios were calculated by averaging NMDAR currents over the last 200 ms before cessation of NMDA application (to get a measure of steady-state current) and then dividing by the peak current amplitude and expressed as a percentage. The NMDA stimulation paradigm was then repeated in the presence of 3 M ifenprodil (IFN). IFN was washed out, and the stimulation paradigm was repeated to monitor recovery of NMDAR current from IFN block. The percentage of current inhibited by IFN was calculated by dividing the average peak NMDAR current of two responses in the presence of IFN by the peak NMDAR current before IFN application.
Visualization of changes in cytosolic free Ca 2ϩ and mitochondrial membrane potential (⌬⌿ m ). Measurements were taken at room temperature (20 -21°C) from primary cultures of age-matched WT or YAC128 MSNs between 9 and 11 DIV. Neurons were loaded with the acetoxymethyl (AM) esters of fura-2, fura-FF or magfura-2 by incubation at 32°C for 45 min in 6.7 M indicator dye in balanced salt solution (BSS; containing 139 mM NaCl, 3.5 mM KCl, 2 mM NaHCO 3 , 10 mM HEPES, 3 mM Na 2 HPO 4 -7H 2 O, 1.8 mM CaCl 2 , 11 mM D-glucose, and 50 M glycine, pH adjusted to 7.35) containing 2.5% bovine serum albumin. The coverslips were then transferred to BSS alone for 15 min before each experiment to ensure hydrolysis of the fluorophore. Experiments were performed using a Zeiss Attofluor digital fluorescence imaging system as previously described (Abdel-Hamid and Baimbridge, 1997) .
Neurons were superfused continuously with BSS at 2.4 ml/min. Regions of interest were sized and placed over the soma of cells that morphologically resembled MSNs. Cells were stimulated with varying concentrations (100 or 500 M) of NMDA (in some experiments in the presence of 0.2 mM Cd 2ϩ , as noted) or 50 mM KCl ϩ 5 M FPL64176 (FPL), with 50 M glycine in all experiments; other compounds were added where indicated. Exposure of cells to 50 mM KCl was achieved by replacing BSS (during the stimulation period) with a high-KCl solution containing the following: 70 mM NaCl, 50 mM KCl, 2 mM NaHCO 3 , 10 mM HEPES, 3 mM Na 2 HPO 4 -7H 2 O, 1.8 mM CaCl 2 , 11 mM D-glucose, and 50 M glycine, pH adjusted to 7.35. Cells that morphologically resembled MSNs and responded to NMDA or KCl/FPL application with an increase in cytosolic Ca 2ϩ were used in the analysis. Data conversion calculations and analysis were performed using Microsoft (Seattle, WA) Excel macros created in Microsoft Visual Basic by Dr. Gordon Rintoul. For measurement of cytosolic Ca 2ϩ , the mean peak F 334 /F 380 response for each cell was calculated by averaging over a 30 s period around the maximal peak response during application of NMDA or KCl/FPL, after subtraction of mean baseline F 334 /F 380 for a 30 s period before stimulus application. The resulting values from each cell were then used to calculate an overall mean value for that experiment; mean and SE for each treatment group were calculated from the means of each experiment for that treatment group (i.e., n is the number of experiments). Estimates of cytosolic calcium recovery were made by expressing the mean F 334 /F 380 value every 5 min after NMDA or KCl/FPL washout as a percentage of the maximal peak F 334 /F 380 response.
Changes in ⌬⌿ m were assessed by single wavelength imaging of rhodamine-123 (rhod-123) fluorescence. This dye is preferentially sequestered in the mitochondria, where its fluorescence is quenched as a result of dye stacking. A loss of ⌬⌿ m results in the redistribution of rhod-123 back into the cytosol, producing an increase in overall cell fluorescence.
In some experiments, the initial loading of Ca 2ϩ indicator (either fura-2 or fura-FF) was followed immediately by an addition of 26.3 mM rhod-123 to the loading buffer to achieve a final concentration of 5.0 M rhod-123. Fifteen minutes after the addition of rhod-123, coverslips were transferred to BSS alone, at room temperature. Dual imaging experiments were then performed in which both cytosolic Ca 2ϩ and ⌬⌿ m were measured simultaneously under the same conditions and in the same age-matched and paired (except for experiments using mPT inhibitors) WT and YAC128 MSNs. The same chamber and imaging system were used as described above, and the same stimulation and measurement paradigm with the addition of an excitation (488 nm) and emission (Ͼ510 nm) cycle for rhod-123. Data for ⌬⌿ m were expressed as the background-corrected change in fluorescence compared with baseline (⌬F/F 0 ). The mean peak ⌬F/F 0 during NMDA application (calculated by averaging over a 30 s period around the peak response) was calculated from measurements for all responding neurons during stimulus (NMDA or KCl/FPL) application in each experiment. The resulting means from each experiment were then used to calculate an overall mean and SE (based on n reflecting the number of experiments) for each treatment group.
For some experiments, mitochondrial Ca 2ϩ content was measured after NMDA application by depolarizing mitochondria using 5 M carbonyl cyanide 3-chlorophenylhydrazone (CCCP), causing mitochondria to release accumulated free Ca 2ϩ into the cytosol. To isolate this source of Ca 2ϩ influx to the cytosol (and exclude Ca 2ϩ entry from extracellular space), neurons were superfused with a Ca 2ϩ -free BSS (same composition as normal BSS above, except 1.8 mM CaCl 2 is replaced by 0.9 mM MgCl 2 ) for 2 min before the addition of CCCP, during the washout of NMDA.
To calculate the lag time between initial changes in Ca 2ϩ and ⌬⌿ m , experiments using the dye pair of fura-2 (because of high sensitivity at low [Ca 2ϩ ]) and rhodamine-123 were analyzed. The time bases for both variables were aligned, and the initiation of fluorescence changes for each variable was recorded. The start time for a fluorescence change was defined as the initial data point in a series of at least five data points that successively increased in a positive direction, after NMDA application. Changes in Ca 2ϩ were observed to always occur before changes in ⌬⌿ m . Data analysis. All data are presented as means Ϯ SEM, unless otherwise noted. t tests and two-way and repeated-measure ANOVAs followed by Bonferroni posttest were performed using GraphPad (San Diego, CA) Prism statistical analysis software. ANOVAs were used where experiments using WT and YAC128 MSNs could be age-matched and performed on the same days (the majority of experiments), allowing for variability in dye-loading and deesterification times, and changes in the intensity of the UV light source over time, to be accounted for equally in all genotype and treatment groups within and across culture batches. Where experiments for both genotypes could not be performed on the same day (those using mPT inhibitors), unpaired t tests were used to analyze data within genotype only, to assess the effects of treatment. All Ca 2ϩ imaging data were baseline-subtracted before analysis. Materials. Acetoxymethyl esters of fura-2, fura-FF, and magfura-2, as well as rhodamine-123, were purchased from Invitrogen. TTX was purchased from Alomone Labs (Israel). Neurobasal medium, B27 with no added supplements, HBSS, and penicillin/streptomycin were purchased from Invitrogen. All other chemicals were purchased from SigmaAldrich (Oakville, Ontario, Canada).
Results

NMDAR current properties are similar for YAC128 and wild-type neurons
Cultured YAC128 MSNs display increased apoptosis 24 h after brief exposure to NMDA compared with WT MSNs (Graham et al., 2006b) . Enhanced excitotoxicity could result from increased NMDAR activation, impaired Ca 2ϩ homeostasis, or mitochondrial dysfunction. To determine the mechanisms underlying augmented NMDAR excitotoxicity, we began by comparing NMDAR-mediated current in YAC128 and WT MSNs. In these and subsequent experiments, we chose 500 M to 1 mM NMDA as an appropriate agonist concentration range for maximally stimulating NMDARs for two reasons. First, the EC 50 for sustained glutamate stimulation of recombinant NR1/NR2B-type NMDARs is ϳ20 M (Chen et al., 2001 ), and NMDA is only a partial NMDAR agonist with a higher EC 50 than glutamate (Banke and Traynelis, 2003) . Second, Alano et al. (2002) found that NMDA concentrations on the order of 500 M to 1 mM were required to saturate NMDAR responses in rat MSNs; our own previous results confirmed that 500 M NMDA was sufficient for maximal induction of apoptosis and evoking the largest changes in cytosolic Ca 2ϩ and mitochondrial depolarization in cultured murine MSNs (Zeron et al., 2004; Shehadeh et al., 2006) . Somewhat surprisingly, we found that the mean NMDA-evoked peak current density recorded from YAC128 MSNs was not significantly different ( p Ͼ 0.05 by unpaired t test) from that of WT MSNs ( Fig. 1 B, left) . As well, we found no significant difference ( p Ͼ 0.05 by unpaired t test) in the mean capacitance of WT and YAC128 MSNs (12.0 Ϯ 0.4 pF, 28 cells vs 13.2 Ϯ 0.9 pF, 20 cells, respectively).
NMDARs desensitize in the continuous presence of agonist, which is one mechanism for attenuating the total current (and Ca 2ϩ ) that enters the neuron during sustained NMDAR activation. If mHtt expression resulted in reduced NMDAR desensitization (i.e., a higher steady-state to peak ratio) this would allow greater current and Ca 2ϩ to enter the cell, facilitating neurotoxic damage. Hence, we assessed the ratio of NMDAR steady-state (I ss ) to peak (I peak ) current in both WT and YAC128 MSNs. However, no significant differences were found in I ss /I peak between genotypes ( Fig. 1 B, right) .
Recent studies suggest NMDAR subunit composition determines activation of distinct signaling pathways (Liu et al., 2004; Massey et al., 2004; Kim et al., 2005; Li et al., 2006) , some of which are linked to cell death (DeRidder et al., 2006) . Moreover, mHtt selectively alters NMDAR-mediated current and apoptosis in a non-neuronal cell line expressing recombinant NR1/NR2B but not NR1/NR2A (Chen et al., 1999) . To determine whether YAC128 MSNs differed from WT MSNs in the NR2B content of NMDARs, we measured the reduction in NMDA-evoked peak current after treatment with the NR1/NR2B-selective inhibitor IFN (3 M) (Williams, 1993) . Our results confirmed that WT and YAC128 MSNs express predominantly NR2B-containing NMDARs, similar to our previous observations in acutely dissociated MSNs from 6-to 11-week-old mice (Zeron et al., 2002) . However, there was no significant difference in the percentage of IFN-sensitive NMDAR current between genotypes (WT: 68.6 Ϯ 2.7%, n ϭ 10 cells; YAC128: 58.0 Ϯ 4.8%, n ϭ 10 cells; p Ͼ 0.05 by unpaired t test). These data indicate that mHtt does not alter the proportion of NR1/NR2B-type NMDARs in cultured YAC128 MSNs.
Altered cytosolic Ca 2؉ clearance after NMDA stimulation in YAC128 MSNs
The above results suggest an apparent paradox: mHtt expression in YAC128 MSNs does not increase the NMDAR peak current density as it does in YAC72 MSNs (Zeron et al., 2002 (Zeron et al., , 2004 or affect desensitization (and hence the integrated NMDAR current), yet NMDA exposure induces apoptosis more efficiently in YAC128 than in WT MSNs (Graham et al., 2006b) , and indeed produces the largest enhancement of apoptosis in YAC128 MSNs relative to YAC18 controls of any stimulus (Shehadeh et al., 2006) . We therefore focused on the downstream consequences of NMDAR activation, monitoring cytosolic free calcium levels by fluorescence imaging of MSNs loaded with the high-affinity calcium dye fura-2 (representative traces shown in Fig. 2 A) . We hypothesized that YAC128 MSNs have a higher resting Ca 2ϩ level, possibly indicative of a stress-induced change (Hansson et al., 2001) or existing mitochondrial impairment (Xiong et al., 2002) that may leave cells more vulnerable to further insult, or else that an equivalent concentration of NMDA would produce a larger increase in cytosolic Ca 2ϩ in YAC128 than WT MSNs.
We found equivalent baseline cytosolic Ca 2ϩ concentrations, as reflected in similar F 334 /F 380 ratios ( p Ͼ 0.05 by paired t test) for WT and YAC128 MSNs (Fig. 2 B) . As well, the maximal peak amplitude of the increase in cytosolic Ca 2ϩ evoked during the application of either 100 M NMDA or 500 M NMDA was not significantly different ( p Ͼ 0.05 by paired t test) between WT and YAC128 MSNs (Fig. 2 B) , similar to the mean whole-cell peak current density evoked by 1 mM NMDA (Fig. 1 B) . The lack of difference in peak NMDAR-evoked Ca 2ϩ increases was confirmed using the lower-affinity Ca 2ϩ indicator magfura-2: F 334 / F 380 ratios using magfura-2 (data not shown) for WT (four experiments, 74 cells total) versus YAC128 (four experiments, 80 cells total) were 0.54 Ϯ 0.16 versus 0.43 Ϯ 0.10, respectively ( p Ͼ 0.05 by paired t test), ruling out the possibility that indicator dye saturation artifactually equalized the Ca 2ϩ responses (Hyrc et al., 1997; Stout and Reynolds, 1999) . Thus, neither resting nor peak cytosolic Ca 2ϩ responses could explain the markedly enhanced NMDA-induced apoptosis found in YAC128 compared with WT MSNs.
In contrast to the similarity in peak Ca 2ϩ response, recovery of cytosolic Ca 2ϩ toward baseline levels after washout of NMDA appeared slower in YAC128 MSNs, as illustrated in representative traces (Fig. 2 A) . To investigate this further, data from a subset of experiments, in which Ca 2ϩ changes were monitored over longer periods, were pooled, and cytosolic Ca 2ϩ recovery was quantified as the percentage of the peak NMDA-induced change remaining over time after washout of NMDA. This analysis revealed a significantly slower recovery rate for YAC128 versus WT MSNs as early as 15 min (repeated-measures ANOVA followed by Bonferroni posttest, *p Ͻ 0.05 at 15 min, *p Ͻ 0.05 at 20 min, **p Ͻ 0.01 at 25 min) post-NMDA (Fig. 2C) , indicating a prolonged elevation of cytosolic Ca 2ϩ in YAC128 MSNs that may be toxic to the cells in and of itself and/or reflect pathological changes in neuronal function, such as the failure of calcium removal to the extracellular space or sequestration into intracellular stores.
Next, we asked whether the slowed cytosolic Ca 2ϩ recovery reflected a general defect in Ca 2ϩ handling in YAC128 MSNs, or whether it was specific for NMDA-induced Ca 2ϩ accumulation. Notably, NMDAR activation under unclamped conditions will lead to activation of voltage-gated calcium channels (VGCCs), which will add to the intracellular Ca 2ϩ load. To stimulate influx of calcium from outside the cell without activating NMDARs, we used 50 mM KCl together with the L-type Ca 2ϩ channel modulator FPL64176 (5 M), a combination that optimizes depolarization-induced Ca 2ϩ influx via VGCCs (Hardingham et al., 1999) . We compared cytosolic Ca 2ϩ responses induced by this stimulus to those evoked by 100 M NMDA, as well as to 500 M NMDA with the panspecific VGCC inhibitor, Cd 2ϩ , to isolate NMDAR-mediated Ca 2ϩ influx from the VGCC-mediated contribution (representative responses shown in Fig. 3A ). It should be noted, however, that 0.2 mM Cd 2ϩ may also partially block NMDARs (Mayer et al., 1989) , so in addition to inhibition of VGCC-mediated Ca 2ϩ entry, the NMDAR-mediated Ca 2ϩ influx is also likely attenuated. When the maximal peak Ca 2ϩ response for NMDA application was normalized to that of KCl/ FPL in paired experiments (Fig. 3B) , we found these responses to be similar for selective activation of VGCCs (KCl/FPL) versus NMDARs (500 M NMDA with 0.2 mM Cd 2ϩ ); however, 100 M NMDA, which will activate both NMDARs and VGCCs, induced a significantly larger maximal cytosolic Ca 2ϩ response than that elicited by paired applications of KCl/FPL. There was no significant difference in peak cytosolic Ca 2ϩ between genotypes for any stimulus (two-way ANOVA; no effect of treatment or genotype). Similar to the previous experiments using 500 M NMDA alone, recovery from a Ca 2ϩ load induced by 100 M NMDA was also significantly slower in YAC128 compared with WT MSNs (twoway ANOVA followed by Bonferroni posttest, *p Ͻ 0.05 at 5 min, **p Ͻ 0.01 at 10 min, ***p Ͻ 0.01 at 15 min). In contrast, recovery from the smaller Ca 2ϩ load induced by membrane depolarization with KCl and FPL or NMDAR activation in the presence of Cd 2ϩ proceeded at equivalent rates in both genotypes (two way ANOVA; no effect of genotype) (Fig. 3C) . Thus, this defect in Ca 2ϩ handling in YAC128 MSNs is revealed under conditions of maximal Ca 2ϩ loading, such as occurs during near-maximal stimulation of NMDARs combined with activation of VGCCs.
Similar cytosolic Ca 2؉ loads induce markedly different changes in ⌬⌿ m in YAC128 compared with WT MSNs
A number of studies demonstrate that NMDAR-mediated excitotoxicity is likely dependent on mitochondrial calcium uptake and overload (Castilho et al., 1998; Stout et al., 1998) , and the extent of mitochondrial membrane depolarization induced by calcium uptake is one indicator of the risk for subsequent apoptotic death (Schinder et al., 1996) . Therefore, we assessed whether the difference in toxicity between WT and YAC128 MSNs correlated with a difference in mitochondrial responses to near-equivalent NMDA-induced cytosolic Ca 2ϩ transients. Figure 4 A shows two typical experiments using two dyes (fura-2 and rhod-123) to simultaneously monitor cytosolic Ca 2ϩ and ⌬⌿ m in WT (top) and YAC128 (bottom) MSNs. Of note (Fig. 4 A,  inset) , the increase in cytosolic Ca 2ϩ indicated by an increase in fura-2 ratio precedes any change in rhod-123 fluorescence (mean lag time between initial changes in fura-2 and rhod-123 signals: 4.39 Ϯ 0.98 s for WT, 5.89 Ϯ 1.2 s for YAC128 MSN, p Ͼ 0.05 by paired t test; n ϭ 8 paired experiments per genotype; total of 131 and 147 neurons for WT and YAC128, respectively, from four different culture batches); this demonstrates the temporal link between the two monitored parameters, consistent with the increase in cytosolic Ca 2ϩ triggering uptake by the mitochondria and, consequently, a reduction in ⌬⌿ m . As expected, there was no difference between WT and YAC128 MSNs ( p Ͼ 0.05 by paired t test) in the calcium signal at baseline or in response to 500 M NMDA (Fig. 4 B, left) . However, the simultaneously monitored changes in ⌬⌿ m were markedly different (*p Ͻ 0.05 by paired t test), with a larger reduction of ⌬⌿ m in YAC128 MSNs indicated by an approximately threefold greater change in rhod-123 fluorescence compared with WT MSNs (Fig. 4 B, right) (*p Ͻ 0.05 by paired t test).
There are several possible reasons for the larger NMDA-induced loss of ⌬⌿ m in YAC128 MSNs. This effect could reflect altered resting mitochondrial function and/or enhanced mitochondrial access to the NMDAR-induced Ca 2ϩ influx leading to increased uptake and depolarization. By applying CCCP (a mitochondrial protonophore that dissipates ⌬⌿ m , thus releasing accumulated rhod-123) (Fig. 4C , example trace) (Toescu and Verkhratsky, 2000) to MSNs loaded with both fura-FF and rhod-123, we established that resting mitochondria in YAC128 MSNs have an average polarization state ( p Ͼ 0.05 by paired t test) similar to those in WT MSNs (peak ⌬F/F: 2.364 Ϯ 0.195 for WT, 2.351 Ϯ 0.476 for YAC128, n ϭ 6 paired experiments per genotype; total of 121 and 113 neurons for WT and YAC128, respectively, from three different culture batches; data are expressed as mean Ϯ SEM). Notably, there is little free Ca 2ϩ released from depolarized mitochondria to the cytosol in the absence of prior NMDAR stimulation, as illustrated in Figure 4C . Furthermore, we used previously established methods to ascertain the efficiency of mitochondrial Ca 2ϩ uptake (Brocard et al., 2001) , in which we measured the area under the curve (AUC) of Ca 2ϩ responses to a 1 min exposure to 500 M NMDA (N) followed 2 min later by a 1 min application of CCCP (C; to release free Ca 2ϩ accumulated by mitochondria) to calculate the C/N ratio (representative experiment shown in Fig. 4 D) . Similar C/N ratios (WT: 0.978 Ϯ 0.097, n ϭ 8 experiments, 92 neurons total; YAC128: 0.805 Ϯ 0.127, n ϭ 6 experiments, 105 neurons total; 3-4 different culture batches, p Ͼ 0.05 by unpaired t test; data are expressed as mean Ϯ SEM) indicated that mitochondria in WT and YAC128 MSNs were equally capable of initially buffering Ca 2ϩ that enters via NMDARs. Moreover, we observed similar, rapid recovery rates after NMDA for WT and YAC128 MSNs (Fig. 4 D) (time to recovery to 50% of the peak was 41.1 Ϯ 4.9 s, n ϭ 8 experiments and 92 cells total for WT; and 36.1 Ϯ 7.1 s, n ϭ 6 experiments and 105 cells total for YAC128; p Ͼ 0.05 by unpaired t test), suggesting that the Ca 2ϩ handling defect is only observed after prolonged NMDAR activity. However, in comparing the total integrated Ca 2ϩ response, it is apparent that the CCCP-induced release of Ca 2ϩ to the cytosol from mitochondria that occurs 2 min after the brief NMDA application is larger than the NMDA-induced cytosolic Ca 2ϩ response (Fig. 4 D) . From these data, we conclude that mitochondria rapidly and efficiently buffer the Ca 2ϩ influx through NMDARs in both WT and YAC128 MSNs.
The dramatically enhanced mitochondrial depolarization found in YAC128 MSNs during 5 min NMDA applications sug- gested that the mPT might be acutely activated in this paradigm. We therefore tested the effect of mPT inhibition on ⌬⌿ m , maximal peak Ca 2ϩ and subsequent recovery toward baseline. Cyclosporin A (CsA) (Fig. 5A) , which binds cyclophilin D, showed no effect ( p Ͼ 0.05 by paired t test) on NMDA-induced peak cytosolic Ca 2ϩ in WT MSNs but significantly (*p Ͻ 0.05 by unpaired t test) reduced peak Ca 2ϩ in YAC128 MSNs. CsA also tended to diminish simultaneously monitored NMDA-induced mitochondrial depolarization in YAC128 MSNs, although the effect was not significant ( p Ͼ 0.05 by unpaired t test). Because CsA inhibits calcineurin as well as the mPT, we tested an alternate mPT inhibitor, bongkrekic acid (BkA) (Fig. 5B) , which binds the adenine nucleotide transporter. BkA (5 M) significantly reduced both peak Ca 2ϩ (*p Ͻ 0.05, unpaired t test) and mitochondrial depolarization (*p Ͻ 0.05, unpaired t test) in YAC128 MSNs, without affecting either parameter ( p Ͼ 0.05, unpaired t test) in WT MSNs. Neither of the mPT inhibitors had an effect on Ca 2ϩ recovery rate over a 15 min period after NMDA application (data not shown).
Discussion
The YAC128 HD mouse model exhibits motor and cognitive changes consistent with human HD (Slow et al., 2003; Van Raamsdonk et al., 2005; Graham et al., 2006a) , with selective striatal neurodegeneration (Slow et al., 2003) , and enhanced MSN apoptosis after striatal quinolinate injection in vivo Graham et al., 2006b) . In YAC128 MSN cultures, NMDAR activation (vs other apoptotic stimuli) produces the largest increase in apoptosis (Shehadeh et al., 2006) . Given results from YAC46 and YAC72 mice (Zeron et al., 2002 (Zeron et al., , 2004 Shehadeh et al., 2006) , these studies suggest a role for altered NMDAR signaling in MSN dysfunction and death. For the first time in the YAC128 model, we examined the relationship between the initiating event of NMDAR activation and downstream interactions between cytosolic Ca 2ϩ and mitochondrial responses underlying enhanced apoptosis of MSNs.
Dissociation between NMDAR current and Ca
2؉ and ⌬⌿ m changes in YAC128 MSNs NMDAR peak current density increases with Htt polyQ length in MSNs cultured from YAC18, YAC46, and YAC72 mice . However, cultured WT and YAC128 MSNs exhibit comparable NMDAR current densities, similar to those of YAC18 MSNs . Thus, the correlation between Htt polyQ length and NMDAR current density in MSNs does not extend to more extreme repeat sizes. Basal activation levels of proteases and/or protein kinases/phosphatases that regulate NMDAR trafficking to and from the surface membrane may be altered as a result of increased cellular stress associated with the extreme polyQ expansion in YAC128 MSNs.
The IFN sensitivity of NMDARs in 9 -11 DIV cultured MSNs, which lack glutamatergic input, is similar to that found in MSNs acutely isolated from 6-to 11-week-old mice, which lose many dendritic synapses during isolation. Thus, the relatively immature cultured MSNs express an NMDAR population similar to those on the soma of more mature neurons in vivo. Our results may reflect signaling largely by extrasynaptic NMDARs, distinct from the mainly triheteromeric (NR1/NR2A/NR2B) receptors found at corticostriatal synapses in vivo (Li et al., 2004) .
In contrast to YAC46 and YAC72 MSNs (Zeron et al., 2004) (Table 1) , but consistent with electrophysiological data presented here, we found no significant difference in NMDA-induced peak cytosolic Ca 2ϩ between WT and YAC128 MSNs. Despite similar Ca 2ϩ loads, YAC128 MSNs exhibited a dramatically enhanced change in ⌬⌿ m downstream of NMDAR activation. Because NMDAR-mediated excitotoxicity depends on mitochondrial Ca 2ϩ uptake and overload (Castilho et al., 1998; Stout et al., 1998) , and the extent of loss of ⌬⌿ m induced by Ca 2ϩ uptake is an indicator for risk of subsequent apoptotic death (Schinder et al., 1996) , our results help explain the exquisite sensitivity of YAC128 MSNs to NMDA-induced apoptosis.
Acute NMDA-evoked mPT induction in YAC128 MSNs
The mPT inhibitors CsA and BkA significantly attenuated NMDA-induced peak Ca 2ϩ in YAC128 MSNs. The change in ⌬⌿ m was also reduced, whereas the recovery rate of the Ca 2ϩ response was not significantly altered. Remarkably, the mPT is activated during a 5 min stimulation of NMDARs in YAC128 MSNs, suggesting early induction of apoptosis. NMDA-induced mPT activation in cultured WT rat MSNs required much longer exposures (Ͼ20 min) to 1 mM NMDA (Alano et al., 2002) ; indeed, we found no evidence of mPT activation during 5 min applications of NMDA in WT MSNs. Moreover, acute NMDAinduced mPT activation in YAC128 MSNs occurred in response to cytosolic Ca 2ϩ levels observed in WT MSNs. YAC72 MSNs, in contrast, have increased NMDA-induced current, Ca 2ϩ levels, and ⌬⌿ m changes compared with WT MSNs (Zeron et al., 2004) . Still, altered Ca 2ϩ homeostasis and mitochondrial dysfunction play a role in enhanced NMDAR toxicity in YAC46 and YAC72 MSNs, because mitochondria isolated from these neurons are more sensitive to Ca 2ϩ -mediated mPT induction (Panov et al., 2002) , and NMDAR currents are equivalent in YAC46 and WT MSNs, whereas NMDAR-mediated Ca 2ϩ responses, mitochondrial depolarization, and apoptosis are all enhanced (Table 1) (Zeron et al., 2004; . Therefore the relative contribution of different mechanisms whereby mHtt enhances NMDAR-mediated apoptosis may depend on CAG repeat length (Fig. 6) .
Several parallels exist between our observations in YAC128 MSNs and studies of mitochondrial dysfunction in HD patients. Lymphoblasts from HD patients are more susceptible to apoptosis, preceded by mitochondrial depolarization and caspase-3 activation (Sawa et al., 1999) . Enhanced stress-induced mitochondrial depolarization was confirmed in mitochondria isolated from HD patients (Panov et al., 2002 (Panov et al., , 2005 or from normal individuals and exposed to GST-fusion proteins expressing an expanded polyQ region (Panov et al., 2003) . When challenged with stepwise additions of calcium, mitochondria impaired by mHtt or a polyQ-containing protein depolarized at smaller calcium loads than control mitochondria (Panov et al., 2003 (Panov et al., , 2005 . Strikingly, mitochondria isolated from lymphoblasts of adult-onset HD patients exhibited a threshold for calcium loads above which they completely depolarized, whereas mitochondria from juvenileonset HD patients showed robust and progressive depolarization to each calcium addition, and complete depolarization occurred at comparatively small calcium loads (Panov et al., 2002) . These data from human HD cells support our model that CAG repeat length modulates mechanisms underlying sensitivity to apoptosis.
Other studies suggest that mitochondrial function is abnormal in YAC128 MSNs. Cytosolic Ca 2ϩ and ⌬⌿ m responses to prolonged NMDAR stimulation are impaired in YAC128 MSNs under conditions of glycolytic inhibition and ATP depletion (Oliveira et al., 2006) . In contrast, our results were obtained in YAC128 MSNs in their normal metabolic state, to elucidate events that could specifically lead to NMDAR-induced apoptosis (Shehadeh et al., 2006) . Inhibitors of the mPT protect against glutamate-induced cell death in YAC128 (line 53) MSNs, further supporting our hypothesis that mPT induction enhances NMDAR-mediated apoptosis in YAC128 MSNs (Tang et al., 2005) . Although the mechanisms underlying mHtt enhancement of sensitivity to calcium-induced mPT are not fully understood, mHtt may promote a H ϩ conductance to explain enhanced mitochondrial depolarization (Panov et al., 2005) , and mHtt appears to directly facilitate the mPT by binding to mitochondrial membranes (Choo et al., 2004) .
MHtt-induced impairment of Ca
2؉ homeostasis Consistent with data from YAC128 line 53 MSNs (Tang et al., 2005) , we found comparable resting cytosolic Ca 2ϩ levels in WT and YAC128 MSNs. Cytosolic Ca 2ϩ recovery is normal after 1 min stimulation of NMDARs, 5 min stimulation of VGCCs, or submaximal stimulation of NMDARs during inhibition of VGCCs. Our results suggest that differences in intracellular Ca 2ϩ handling, such as mitochondrial buffering, become apparent during prolonged NMDA application that results in maximal Ca 2ϩ loading (Alano et al., 2002; Zeron et al., 2004) , as occurs with near-saturating NMDAR stimulation combined with VGCC activation. In support of this conclusion, of several stimuli that increased intracellular calcium levels, NMDA stimulation produced the largest enhancement of apoptosis in MSNs from YAC128 compared with YAC18 mice (Shehadeh et al., 2006) .
Other intracellular Ca 2ϩ stores and extrusion mechanisms likely contribute to impaired Ca 2ϩ homeostasis. Indeed, mHtt enhances IP 3 receptor (IP 3 R) sensitivity (Tang et al., 2003) and augments toxicity of mGluR1/5-mediated activation of IP 3 Rs in YAC128 MSNs (Tang et al., 2005) , a mechanism unlikely to be activated in our paradigm. Consistent with our finding of slowed Ca 2ϩ recovery after NMDAR activation in YAC128 MSNs, repetitive glutamate pulses produced a gradual Ca 2ϩ elevation in YAC128 (line 53), but not WT MSNs over a similar time frame (Tang et al., 2005) . The Na ϩ /Ca 2ϩ exchanger isoform 3 (NCX3) is cleaved by calpains in striatal tissue after focal ischemia and in cerebellar granule neurons under excitotoxic conditions (Bano et al., 2005) . Similar calpain activation may occur in YAC128 MSNs after NMDAR activity, impairing an important homeostatic Ca 2ϩ clearance route. Impaired recovery of cytosolic Ca 2ϩ in YAC128 MSNs after NMDA challenge may influence downstream toxic consequences mediated by Ca 2ϩ -activated pathways. In excitotoxic-resistant Zeron et al. (2002 Zeron et al. ( , 2004 , Shehadeh et al. (2006), and . FVB/N indicates mouse strain background for WT and YAC transgenic mice.
Figure 6.
A general model for the main excitotoxic events in the various YAC HD models. Previous research established that enhanced NMDAR activation (step 1) leads to elevated peak cytosolic Ca 2ϩ (step 2) and subsequent mitochondrial depolarization (step 3), caspase activation (step 4), and apoptosis (step 5) in YAC46 and YAC72 MSNs. In the YAC128 mouse model, steps 1 and 2 do not appear to play a role in the enhancement of apoptosis for YAC128 versus WT MSNs. The key excitotoxic step augmented in YAC128 MSNs occurs at the level of the mitochondria (step 3), but is still dependent on NMDAR activation. Thus, the increased sensitivity to NMDA-induced toxicity occurs at a later point in the sequence of events leading to apoptotic death in YAC128 compared with YAC72 MSNs. Delayed recovery from NMDA-induced Ca 2ϩ loads in YAC128 MSNs may also serve to enhance calpain activity levels after intense NMDAR activity.
R6/2 mice, elevated resting Ca 2ϩ in MSNs may cause neuronal dysfunction underlying behavioral deficits preceding neuronal death (Hansson et al., 2001) . A similar phenomenon, stemming from cumulative dysfunction downstream of NMDAR activity, may manifest over time in YAC128 mice, which show behavioral changes preceding neuronal loss (Slow et al., 2003) . Indeed, a number of factors impinging on the striatum, including relative enrichment of NR2B (Rigby et al., 1996) , the presence of dopamine and other oxidative stressors, and an increased susceptibility of striatal mitochondria to Ca 2ϩ -induced mPT induction (Brustovetsky et al., 2003) , may act synergistically with mHttinduced deficits such as impairment of BDNF production (Zuccato et al., 2001) , aberrant cortical presynaptic activity (Cepeda et al., 2003) , and pathological changes reported here, to render MSNs particularly vulnerable in HD.
Summary
Our data indicate that intense NMDAR activation produces acute mitochondrial dysfunction, mPT activation, and inability to regulate cytosolic Ca 2ϩ in YAC128 MSNs. Diverging from YAC models with shorter polyQ expansions, enhanced NMDAinduced apoptosis is largely determined by increased susceptibility to Ca 2ϩ -induced mitochondrial depolarization and mPT activation. These results may explain why equivalent NMDAR currents produce marked differences in apoptosis in YAC128 compared with WT MSNs and help to refine therapeutic strategies in YAC HD mouse models with different CAG sizes. Signaling pathways activated by strong NMDAR stimulation converge on mitochondria in all YAC HD models, suggesting that bolstering mitochondrial function and/or inhibiting the mPT are viable targets for ameliorating excitotoxicity-driven apoptosis in HD.
